MAGE-3 (149-160)

MAGE-3 (149-160) is a synthetic peptide fragment derived from the melanoma-associated antigen 3 (MAGE-3) protein, a member of the MAGE family of cancer-testis antigens. As a well-characterized epitope, this peptide comprises amino acids 149 to 160 of the full-length MAGE-3 protein and is recognized for its immunological relevance, particularly in the context of tumor antigenicity and T cell recognition. Its defined sequence and immunogenic properties have made it a valuable reagent in tumor immunology, epitope mapping, and the study of antigen processing and presentation. MAGE-3 (149-160) is widely used in research settings to elucidate the mechanisms of immune recognition of cancer cells and to support the development of novel immunological assays and screening platforms.

Epitope mapping: Researchers utilize this peptide fragment to identify and characterize specific T cell epitopes within the MAGE-3 protein. By employing it in peptide binding assays or T cell activation studies, investigators can determine which segments of the MAGE-3 antigen are most immunologically relevant. This application is crucial for dissecting the fine specificity of T cell responses in the context of cancer immunology, enabling the precise mapping of immune-dominant regions and informing the design of targeted immunotherapeutic strategies.

Antigen presentation studies: The MAGE-3 (149-160) peptide is instrumental in examining the mechanisms of antigen processing and presentation by major histocompatibility complex (MHC) molecules. By pulsing antigen-presenting cells with this defined peptide, researchers can assess the efficiency and specificity of MHC class I or II peptide loading, as well as the subsequent activation of cytotoxic or helper T lymphocytes. Such studies are fundamental for understanding the molecular interactions that govern immune surveillance and tumor immune evasion.

Immunoassay development: Owing to its well-defined sequence and immunogenic properties, this peptide serves as a standard in the development of peptide-based immunoassays. It can be used as a positive control or calibrator in enzyme-linked immunospot (ELISPOT), enzyme-linked immunosorbent assay (ELISA), or flow cytometry-based assays designed to quantify antigen-specific T cell responses. The availability of a synthetic, sequence-defined peptide ensures assay reproducibility and facilitates the benchmarking of immune monitoring platforms in cancer research.

Peptide-MHC tetramer generation: The MAGE-3 (149-160) sequence is frequently employed in the synthesis of peptide-MHC tetramers, which are powerful tools for the detection and enumeration of antigen-specific T cell populations by flow cytometry. By incorporating this peptide into MHC complexes, researchers can selectively label T cells with specificity for the MAGE-3 epitope, allowing for detailed phenotypic and functional characterization of tumor-reactive lymphocytes. This application is particularly valuable in monitoring immune responses in experimental cancer models and in ex vivo studies of patient-derived samples.

Peptide library screening: In the context of high-throughput immunological research, this peptide can be used as part of overlapping peptide libraries to screen for T cell reactivity across the MAGE-3 protein. Such libraries enable systematic evaluation of immune recognition patterns, supporting the identification of novel epitopes and the assessment of cross-reactivity within the MAGE antigen family. The use of well-characterized synthetic peptides such as this one enhances the reliability and interpretability of screening data, advancing the understanding of tumor antigenicity and immune targeting.

1. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

5. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef